CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844367680
- Phone
- (857) 760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $481,506
- in 2 filings
Net −$481,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-27 | ARCH Venture Partners XII, LLC 10% owner | Purchase | +24,504 | $12.31 | $302K | 3,783,387 |
| 2023-09-26 | Burow Kristina Director | Purchase | +34,000 | $11.73 | $399K | 3,758,883 |
| 2023-09-26 | ARCH Venture Partners XII, LLC 10% owner | Purchase | +34,000 | $11.73 | $399K | 3,758,883 |
| 2023-09-25 | ARCH Venture Partners XII, LLC 10% owner | Purchase | +30,773 | $10.80 | $332K | 3,694,916 |
| 2023-09-25 | ARCH Venture Partners XII, LLC 10% owner | Purchase | +29,967 | $11.65 | $349K | 3,724,883 |
| 2023-09-25 | Burow Kristina Director | Purchase | +30,773 | $10.80 | $332K | 3,694,916 |
| 2023-09-25 | Burow Kristina Director | Purchase | +29,967 | $11.65 | $349K | 3,724,883 |
| 2023-09-22 | ARCH Venture Partners XII, LLC 10% owner | Purchase | +40,000 | $11.14 | $446K | 3,664,143 |
| 2023-09-22 | Burow Kristina Director | Purchase | +40,000 | $11.14 | $446K | 3,664,143 |
| 2023-09-19 | FMR LLC See Remark 1 | Conversion | +3,475,646 | 5,387,375 | ||
| 2023-09-19 | FMR LLC See Remark 1 | Conversion | +84,965 | 5,472,340 | ||
| 2023-09-19 | FMR LLC See Remark 1 | Conversion | +63,724 | 63,724 | ||
| 2023-09-19 | FMR LLC See Remark 1 | Conversion | +88,289 | 88,289 | ||
| 2023-09-19 | FMR LLC See Remark 1 | Conversion · Series A-2 Preferred Stock | −63,724 | 0 | ||
| 2023-09-19 | FMR LLC See Remark 1 | Conversion · Series A-2 Preferred Stock | −3,475,646 | 0 | ||
| 2023-09-19 | FMR LLC See Remark 1 | Conversion · Series B Preferred Stock | −84,965 | 0 | ||
| 2023-09-19 | FMR LLC See Remark 1 | Conversion · Series A-2 Preferred Stock | −88,289 | 0 | ||
| 2023-09-19 | Burow Kristina Director | Conversion | +13,620 | 13,620 | ||
| 2023-09-19 | Burow Kristina Director | Conversion | +684,167 | 684,167 | ||
| 2023-09-19 | Burow Kristina Director | Conversion | +1,144,973 | 1,144,973 |
Page 17 of 20 · 384 trades